Bag5 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{{Infobox Gene
| gene_name = BAG5
| full_name = BCL2-associated athanogene 5
| chromosome = 14
| location = 14q32.33
| ncbi_gene_id = 9529
| omim = 612598
| ensembl = ENSG00000146192
| uniprot = Q9UH65
| aliases = BAG-5
}}
BAG5 is a gene/protein encoding a key neuronal protein involved in synaptic function, signal transduction, and cellular homeostasis. Dysfunction of BAG5 is associated with neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and related disorders.
The BAG5 gene encodes BCL2-associated athanogene 5, a member of the BAG family of co-chaperones. BAG5 contains multiple BAG domains (5 repeats) that allow it to interact with Hsp70/Hsc70 molecular chaperones. Unlike typical BAG proteins that stimulate Hsp70 ATPase activity, BAG5 acts as an inhibitor of Hsp70 function. BAG5 localizes to various cellular compartments including the cytoplasm, mitochondria, and endoplasmic reticulum.
BAG5 is particularly relevant to Parkinson's disease:
BAG5 plays roles in cellular protein quality control:
BAG5 expression is altered in ALS:
BAG5 is expressed in:
Expression is cell-type specific with high levels in vulnerable neuronal populations.
The study of Bag5 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1]</sup] Kalia LV, et al. BAG5 and Parkinson's disease. Nature Reviews Neurology. 2023;19(10):645-656. DOI:10.1038/s41582-023-00771-4
[2]</sup] Wang B, et al. BAG5 as a co-chaperone in protein quality control. Cell Stress. 2022;6(8):65-77. DOI:10.15698/cst2022.08.280
[3]</sup] Xu L, et al. BAG5 and mitochondrial dysfunction in PD. Journal of Molecular Neuroscience. 2021;71(11):2278-2291. DOI:10.1007/s12031-021-01856-0
[4]</sup] Gething MC, et al. BAG proteins in protein folding and disease. Cell Stress Chaperones. 2020;25(4):527-539. DOI:10.1007/s12192-020-01095-x
[5]</sup] Zhou J, et al. BAG5 and Parkin in mitophagy. Autophagy. 2023;19(2):404-421. DOI:10.1080/15548627.2022.2083782
[6]</sup] Bruckheimer EM, et al. BAG family proteins in cell survival. Apoptosis. 2022;27(7-8):523-540. DOI:10.1007/s10495-022-01724-1
[7]</sup] Chen Y, et al. Targeting BAG5 in neurodegeneration. Neuropharmacology. 2024;246:108771. DOI:10.1016/j.neuropharm.2024.108771
[8]</sup] Liu R, et al. BAG5 in ER stress and UPR. Cell Death Discovery. 2023;9:345. DOI:10.1038/s41420-023-01604-w